MedPath

Intelligent Diagnosis and Treatment Model for Insomnia Disorder

Recruiting
Conditions
Insomnia
Interventions
Other: Routine clinical treatment
Registration Number
NCT06375447
Lead Sponsor
Xuanwu Hospital, Beijing
Brief Summary

To establish a multicenter, multi-dimensional cohort on insomnia disorder and to develop an intelligent model for the diagnosis and treatment of insomnia disorder.

Detailed Description

The study endeavors to establish a multicenter cohort comprising 16,000 individuals diagnosed with insomnia disorder, with a subsequent 2-year follow-up. Objectives encompass elucidating the natural development of insomnia disorder within diverse populations, identifying associated factors, and evaluating the short-term and long-term impacts on physiological, psychological, and social functions in insomnia disorder. Additionally, the research aims to devise early screening methodologies, precise assessments, and innovative disease classifications utilizing real-time assessment technology within the insomnia disorder cohort. Furthermore, the investigation seeks to ascertain graded diagnoses, treatment modalities, and prognostic indicators based on advanced multi-dimensional real-time assessment technology applied to a substantial insomnia disorder cohort. Finally, the study aims to refine remote interactive diagnostic and treatment modalities tailored to diverse age groups, culminating in developing a systematic graded diagnostic and treatment framework for insomnia disorder.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
16000
Inclusion Criteria
  1. A complaint of insomnia;
  2. Age between 18 and 75;
  3. Able to fill out the scale on their own;
  4. Agree to sign the informed consent to participate in the study and cooperate in completing the follow-up visit.
Exclusion Criteria

1.A current or history of comorbid Axis I psychiatric disorders.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with insomniaRoutine clinical treatmentPatients with a complaint about insomnia.
Primary Outcome Measures
NameTimeMethod
The change of Pittsburgh Sleep Quality Index (PSQI) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

The PSQI consists of 7 factors ranging from 0 to 3 points, and the total score ranges from 0 to 21 with higher scores indicating poorer quality.

Secondary Outcome Measures
NameTimeMethod
The change of Epworth Sleepiness Scale (ESS) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

The ESS assessing daytime sleepiness consists of 8-items on a 4-point Likert scale, and the total score ranges from 0 to 24 with higher scores indicating more sleepiness.

The change of PHQ-15 total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

The PHQ-15 measuring somatic distress consists of 15 items, and the total score ranges from 0 to 30 with higher scores indicating more severe somatic distress.

The change of Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

The DBAS assessing sleep related cognitions in 16 item rated on a 10-point Likert scale, and the total score ranges from 0 to 160 with higher scores indicating more intensive disfunctional beliefs.

The change of PDQ-D-5 total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

The PDQ-D-5 assessing perceived cognitive deficits from the patient's perspective consists of 5 items, and the total score ranges from 0 to 20 with higher scores indicating greater perceived deficit.

The change of Life Events Scale (LES) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

The LES assessing the perceived stress and number of stressful life events experienced consists of 48 items which are classified into three dimensions: family life events (28 items), work and study events (13 items), and social events (7 items) with higher scores in LES perceived greater stressfulness.

The change of sleep onset latency from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

Sleep onset latency is assessed with the Carney (2012) consensus sleep diary. This is measured in minutes (higher scores indicating longer sleep onset latency).

The change of total sleep time from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

Total sleep time is assessed with the Carney (2012) consensus sleep diary. This is measured in minutes (higher scores indicating longer total sleep time).

The change of time in bed from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

Time in bed is assessed with the Carney (2012) consensus sleep diary. This is measured in minutes (higher scores indicating longer time in bed).

The change of Short Form 36 (SF-36) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

The SF-36 quantifing the quality of life in relation to health status consists of 36-items with eight areas covering physical functioning, role limitations brought on by physical issues, bodily pain, general health perceptions, vitality, social functioning, role limitations brought on by emotional issues, and perceived mental health. The total score ranges from 0-100 (the worst possible to the most possible).

The change of Insomnia severity index (ISI) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

The ISI reporting insomnia symptoms severity consists of 7-items on a 5-point Likert scale, and the total score ranges from 0 to 28 with higher scores indicating more severe insomnia.

The change of SHAPS total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

The SHAPS assessing anhedonia consists of 14 items, and the total score ranges from 14 to 56 with higher scores indicating more serious the anhedonia.

The change of wake after sleep onset from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

Wake after sleep onset is assessed with the Carney (2012) consensus sleep diary. This is measured in minutes (higher scores indicating longer wake after sleep onset).

The change of terminal wakefulness from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

Terminal wakefulness is assessed with the Carney (2012) consensus sleep diary. This is measured in minutes (higher scores indicating longer terminal wakefulness).

The change of sleep efficiency from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months.Baseline, 3 months, 6 months, 12 months, 18 months, 24 months

Sleep efficiency is assessed with the Carney (2012) consensus sleep diary. This is measured in percentage (higher scores indicating better sleep efficiency).

Trial Locations

Locations (5)

Xuanwu Hospital, Capital Medical University

🇨🇳

Beijing, China

Beijing Tiantan Hospital, Capital Medical University

🇨🇳

Beijing, China

The First Bethune Hospital of Jilin University

🇨🇳

Changchun, China

The Second Affiliated Hospital of Soochow University

🇨🇳

Suzhou, China

West China Hospital, Sichuan University

🇨🇳

Chengdu, China

© Copyright 2025. All Rights Reserved by MedPath